Chewy, Inc.

Chewy, Inc. (CHWY) Market Cap

Chewy, Inc. has a market capitalization of $9.36B.

Price: $22.60

-0.22 (-0.96%)

Market Cap: 9.36B

NYSE · time unavailable

CEO: Sumit Singh

Sector: Consumer Cyclical

Industry: Specialty Retail

IPO Date: 2019-06-14

Website: https://www.chewy.com

Chewy, Inc. (CHWY) - Company Information

Market Cap: 9.36B|Sector: Consumer Cyclical

Company Profile

Chewy, Inc., along with its affiliated entities, functions exclusively as an online retail enterprise within the United States. Through its primary website, chewy.com, and its mobile applications, the company provides a comprehensive range of products and services tailored for nearly every type of domestic companion, including canines, felines, aquatic pets, birds, small mammals, horses, and even reptiles. Customers can procure everything from essential pet food and treats to necessary supplies, prescribed medications, and other health and wellness items. This extensive inventory includes roughly 100,000 unique products supplied by approximately 3,000 different partner brands. Chewy was established in 2010 and maintains its corporate headquarters in Dania Beach, Florida.

Analyst Sentiment

92%
Strong Buy

From 25 Active Polls

1Y Forecast: $31.54

▲ +39.6% Potential Upside

Consensus Target Metrics

Low Bound

$23

Median

$30

High Bound

$43

Average

$32

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$31.54
▲ +39.56% Upside
Low Target
$23.00
2% Risk
Median Target
$30.00
33% Mid
High Target
$43.00
90% Max
Consensus
Buy
31 / 38 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MMay 3, 2026Feb 1, 2026Nov 2, 2025Aug 3, 2025May 4, 2025Feb 2, 2025Oct 27, 2024Jul 28, 2024
Market Cap ($M)9,35910,17811,76513,63514,84115,64215,55511,10510,473
Enterprise Value ($M)9,35810,17711,46213,48314,74315,52615,46111,10910,295
Price to Earnings Ratio (P/E)48.0968.2278.8658.7959.7263.02170.57705.268.71
Price/Earnings-to-Growth Ratio (PEG)16.60147.1613.281058.52
Price to Sales Ratio (P/S)0.733.123.604.384.785.024.793.863.66
Price to Book Ratio (P/B)22.0823.9923.6329.0538.0641.6559.4949.7021.52
Price to Free Cash Flow Ratio (P/FCF)16.01143.7550.7177.56140.14321.1999.3273.17114.47
Enterprise Value to Sales (EV/Sales)3.123.514.334.754.984.763.863.60
Enterprise Value to EBITDA (EV/EBITDA)25.40126.73148.66130.27137.14142.18557.23185.67134.62
Debt to Equity Ratio-0.001.141.121.111.271.331.922.291.06

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CHEWY INC CLASS A (CHWY) — Investment Overview

🧩 Business Model Overview

CHEWY operates a direct-to-consumer pet retail platform that blends an e-commerce storefront with a centralized fulfillment engine. Customers buy consumables (food, treats, supplements) and durable/recurring categories (toys, grooming supplies), with fulfillment optimized through distribution centers and a dedicated customer operations function. A key element of the value chain is customer convenience plus inventory availability: SKUs are stocked and routed for fast delivery, and the company’s pharmacy and support workflows reduce friction for repeat purchases.

Customer stickiness is reinforced through repeat ordering behavior and programmatic purchasing (e.g., scheduled replenishment/auto-ship style mechanics), supported by saved preferences, order history, and responsive customer service.

💰 Revenue Streams & Monetisation Model

Monetisation is primarily product sales, including:

  • Core pet consumables (food, treats, litter, grooming essentials) driving high-frequency purchasing.
  • Health-related offerings through pet pharmacy (Rx and non-Rx where permitted), which can command structurally different economics versus general merchandise and often supports higher repeat rates.
  • Ancillary services and category extensions that broaden the basket (supplementary pet needs, preventive health-related assortments, and other platform-enabled offerings depending on jurisdiction).

While most sales are transactional, the business has a “recurring-like” profile because the majority of categories are consumables. Margin dynamics are driven by product mix (higher-margin health-related assortments), pricing discipline, and fulfillment efficiency (handling cost per order, delivery speed trade-offs, and inventory turns).

🧠 Competitive Advantages & Market Positioning

CHEWY’s moat is best characterized as switching costs and operational cost advantages created through customer data/experience, replenishment behavior, and fulfillment scale.

  • Switching costs (practical, not contractual): order history, saved pet profiles/preferences, category-specific recommendations, and simplified reorder flows make “restarting” purchasing elsewhere less convenient.
  • Replenishment behavior: scheduled repurchase patterns convert many categories into repeat purchases, supporting better visibility into demand and a higher share of wallet over time.
  • Fulfillment and purchasing scale: a broad catalog and distribution footprint allow improved unit economics versus smaller niche players and can support competitive pricing without constant promotional dependence.

Competitive benchmarking (industry focus vs. rivals):

  • PetSmart and Petco: these are omnichannel retailers with physical store footprints and loyalty programs. Their positioning leans on in-store retail adjacency; CHEWY’s competitive advantage is convenience-first direct delivery plus faster reordering through its digital customer experience.
  • Amazon: a broad online retailer with aggressive logistics capabilities and marketplace dynamics. CHEWY competes more directly on pet-specialization breadth, pharmacy-related offerings, and customer service tailored to pet needs rather than general merchandise assortment.
  • Walmart / other mass retailers: strong low-price anchors on selected categories. CHEWY’s differentiator is category depth, online convenience, and the compounding effect of pet profiles and reorder workflows that reduce customer churn.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, the growth thesis rests on TAM expansion from ongoing shift toward e-commerce for everyday categories, plus share gains from customer experience advantages in pet-specific online retail.

  • Structural shift to online pet replenishment: pets require frequent purchases, and online reduces trips and improves availability versus fragmented local inventory.
  • Category expansion: deeper penetration into health-related categories and higher-frequency consumables can increase basket size and improve repeat cadence.
  • Customer lifetime value compounding: retention and reorder mechanics support gradual improvements in profitability per customer as cohorts mature.
  • Operational leverage: as order volume scales, distribution and order-processing efficiencies typically improve unit economics, enabling reinvestment in service levels and assortment.
  • Service and ecosystem adjacency: pharmacy-enabled workflows and supportive customer care can strengthen engagement beyond “one-off” product shopping.

⚠ Risk Factors to Monitor

  • Competitive pricing pressure: large omnichannel competitors and marketplace platforms can compress margins, especially in high-turn commoditized categories.
  • Fulfillment and delivery economics: changes in shipping costs, labor costs, or network utilization can reduce gross margin or increase operating expenses.
  • Inventory, working capital, and demand forecasting: pet retail includes seasonal and promotional sensitivity; mispricing or incorrect demand assumptions can lead to markdowns and cash flow drag.
  • Regulatory and compliance constraints: pharmacy-related products are subject to evolving regulations and state-by-state requirements; compliance costs and product/channel restrictions can affect assortment and economics.
  • Supply chain and product quality risks: pet food and health-related categories face product recall risk and quality controls; incidents can create reputational and operational costs.

📊 Valuation & Market View

The market often values CHEWY and similar direct-to-consumer retailers using a combination of revenue-based multiples and cash flow/operating margin sustainability rather than traditional asset-heavy metrics. Key valuation drivers typically include:

  • Gross margin durability driven by mix (health-related vs. general merchandise), pricing discipline, and fulfillment cost control.
  • Operating leverage: evidence that scaling fulfillment and customer operations improves operating expense ratios over time.
  • Cash conversion: inventory turns, working capital efficiency, and the relationship between growth and free cash flow.
  • Customer quality: retention and cohort behavior that indicate the platform can sustain growth without progressively higher marketing intensity.

As a result, narrative risk typically concentrates around the company’s ability to maintain differentiated service while defending margins in a highly competitive online retail environment.

🔍 Investment Takeaway

CHEWY’s long-term investment case is anchored in a durable switching-cost ecosystem built from pet profiles, reorder convenience, and customer support—supported by scale-driven fulfillment economics. The primary question for sustained outperformance is whether management can defend gross margin and improve cash conversion while navigating intense competition from omnichannel retailers and large online marketplaces.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for CHWY.

zacks.com2026-07-30

Chewy (CHWY) Stock Falls Amid Market Uptick: What Investors Need to Know

In the closing of the recent trading day, Chewy (CHWY) stood at $22.82, denoting a -2.06% move from the preceding trading day.

zacks.com2026-07-29

Here is What to Know Beyond Why Chewy (CHWY) is a Trending Stock

Chewy (CHWY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

gurufocus.com2026-07-27

Chewy Inc (CHWY) Stock Up 4.5% and Still Undervalued -- GF Score: 68/100

On July 27, 2026, Chewy Inc (CHWY) shares rose 4.5% today, trading at $21.80. The stock has experienced a volatile year, with a 52-week range of $17.40 to $43.5

zacks.com2026-07-24

Chewy (CHWY) Beats Stock Market Upswing: What Investors Need to Know

Chewy (CHWY) closed the most recent trading day at $20.86, moving +1.96% from the previous trading session.

zacks.com2026-07-23

Here's Why Chewy (CHWY) Fell More Than Broader Market

In the latest trading session, Chewy (CHWY) closed at $20.46, marking a -4.93% move from the previous day.

fool.com2026-07-23

Chewy vs. Petco Health and Wellness: E-commerce Growth vs. Omnichannel Stability

Chewy currently looks stronger on revenue, consistently generating higher top-line totals and maintaining a general upward trajectory compared to its peer. Over roughly the last eight quarters, Chewy has seen a slow but steady increase in quarter-over-quarter revenue, while Petco Health and Wellness has maintained a largely flat performance.

fool.com2026-07-23

Prediction: Chewy Stock Will Rebound Over the Next Year. Here's Why.

Investors have ignored this online retailer for too long.

defenseworld.net2026-07-21

Bank of New York Mellon Corp Trims Position in Chewy $CHWY

Bank of New York Mellon Corp reduced its stake in Chewy (NYSE: CHWY) by 1.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,252,907 shares of the company's stock after selling 83,722 shares during the quarter. Bank of New York Mellon Corp

defenseworld.net2026-07-21

Allspring Global Investments Holdings LLC Has $23.99 Million Stake in Chewy $CHWY

Allspring Global Investments Holdings LLC reduced its stake in shares of Chewy (NYSE: CHWY) by 22.0% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 901,118 shares of the company's stock after selling 254,811 shares during the period. Allspring Global

fool.com2026-07-17

Chewy vs. Walmart: Which Consumer Stock Is a Better Buy in 2026?

Chewy is expanding its reach beyond online retail by integrating physical veterinary clinics and professional health services. Walmart continues to dominate the global retail landscape by leveraging its massive scale and growing advertising business.

zacks.com2026-07-16

Chewy (CHWY) Gains As Market Dips: What You Should Know

Chewy (CHWY) closed the most recent trading day at $21.53, moving +1.51% from the previous trading session.

zacks.com2026-07-16

Chewy (CHWY) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Chewy (CHWY). This makes it worthwhile to examine what the stock has in store.

zacks.com2026-07-15

Wall Street Bulls Look Optimistic About Chewy (CHWY): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

zacks.com2026-07-14

How Pet Healthcare Could Shape Chewy's Future Growth & Profitability?

CHWY is expanding its healthcare platform through Vet Care and Modern Animal to drive customer growth and long-term profitability.

seekingalpha.com2026-07-14

Carillon Eagle Mid Cap Growth Fund Q2 2026 Portfolio Review

Carillon Eagle Mid Cap Growth Fund stocks delivered solid results in the second quarter. Top securities in the quarter were Datadog, Marvell, Vertiv, Teradyne and Macom Technology Solutions. Top securities in the quarter were Datadog, Marvell, Vertiv, Teradyne and Macom Technology Solutions.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-05-03

"CHWY Q1’26 (ended 2026-05-03): Revenue $3.26B, Net Income $39.2M (EPS $0.09). Revenue was flat QoQ versus Q4’25 (~0.0%) and grew +4.8% YoY versus Q1’25 ($3.116B). Net income declined sharply QoQ (from $62.0M in Q4’25 to $39.2M) and was down YoY (from $62.4M in Q1’25), resulting in negative earnings momentum despite modest top-line growth. Profitability contracted: gross margin was ~29.4% in Q1’26 (slightly lower than Q2–Q3’25 ~30–30.4%), while operating income margin fell to ~1.3% from ~2.1–2.5% earlier in 2025. Cash flow remains positive, with operating cash flow of $108.5M and free cash flow of $70.8M, but working capital was a drag in the quarter (change in working capital -$104.6M). Balance sheet resilience looks mixed: total assets dipped to $3.30B from $3.59B in Q4’25, equity fell to $424M, and cash declined materially (from $878.8M to $485.2M). Shareholder returns are weak: price is down -20.83% over the last year with no dividend (and buybacks of -$253M in the quarter), and there is no 1y positive momentum to offset the earnings softness. Analyst targets show limited upside with the consensus target ($38.9) above the current price ($27.52)."

Revenue Growth

Positive

Revenue was essentially flat QoQ (Q1’26 $3.265B vs Q4’25 $3.265B) and up +4.8% YoY (vs Q1’25 $3.116B), indicating modest growth but no acceleration.

Profitability

Neutral

Margins contracted materially: net margin ~1.2% in Q1’26 vs ~2.0% in Q1’25 and ~1.9% in Q3’25. Net income fell QoQ ($62.0M/Q4’25 -> $39.2M/Q1’26) and YoY ($62.4M/Q1’25 -> $39.2M/Q1’26), despite revenue stability.

Cash Flow Quality

Fair

Operating cash flow was positive ($108.5M) but down QoQ (Q4’25 OCF $263.4M). Working capital was a drag (-$104.6M), yet free cash flow remained positive ($70.8M). Buybacks continued (-$253.3M) and there is no dividend.

Leverage & Balance Sheet

Fair

Total assets declined QoQ ($3.59B -> $3.30B). Equity fell to $424M from $498M, and cash decreased sharply ($878.8M -> $520.1M cash & ST investments). Total debt eased slightly (total debt $556.8M -> $484.1M) and net debt remains near flat/negative.

Shareholder Returns

Caution

Total return backdrop is negative: stock price is down -20.83% over 1 year (no >20% positive momentum). Buybacks supported cash use in Q1’26 (-$253M) but did not offset the share-price decline; dividend yield is 0%.

Analyst Sentiment & Valuation

Neutral

Street upside appears limited but positive: consensus target $38.9 vs current $27.52 suggests ~41% potential upside. However, the high sensitivity to earnings/margins keeps the risk elevated.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

CHWY delivered Q1 growth that held up despite a softer consumer backdrop: net sales rose 7.7% to ~$3.36B and adjusted EBITDA margin expanded ~130 bps to 7.5%, supported by >25% flow-through from structural drivers (sponsored ads, mix, supply chain efficiency, and OpEx discipline). Free cash flow surged to ~$71M (+>45% YoY). However, management updated FY2026 guidance to reflect incremental premiumization/attach-rate pressure, lowering the expected pace of NSPAC growth and steering active customer adds toward the lower end of the prior quarterly range. Gross margin cadence is expected to be uneven in Q2 due to difficult MAP-related comps and fuel surcharge headwinds, while margin expansion should re-accelerate in the back half. Strategic momentum remains centered on Autoship durability, Chewy Health/Vet Care expansion (Modern Animal integration; ~60 clinics exiting FY26), and AI/automation efficiency benefits (low-tens-of-millions in FY26, ramping into FY27+).

AI IconGrowth Catalysts

  • Autoship customer sales outgrew company growth: >10% YoY to $2.83B and 84.4% of net sales
  • Health penetration and cross-category engagement supporting NSPAC $597 (+4.6% YoY normalized)
  • Sponsored ads growth and favorable category mix driving gross margin expansion

Business Development

  • Modern Animal acquisition (closed shortly after quarter end) adds a complementary CVC footprint
  • SmartPak acquisition closed in Q1; full-year 2026 net sales contribution guided at ~$80M
  • Named financing: $600M Term Loan B launched (subsequent to quarter end)

AI IconFinancial Highlights

  • Q1 net sales +7.7% YoY to ~$3.36B
  • Adjusted EBITDA margin 7.5% (+~130 bps YoY) with >25% EBITDA flow-through
  • Gross margin 30.1% (+~50 bps YoY) including low single-digit million dollar fuel surcharge pass-through impact via carrier partners
  • Q1 adjusted diluted EPS $0.43; adjusted net income ~$180M
  • Q1 free cash flow ~$71M (+>45% YoY) vs ~$109M net cash from operating activities and ~$38M capex
  • Q1 non-GAAP SG&A ~$593M (17.7% of net sales) with ~90 bps YoY SG&A leverage; ~$10M transaction/integration costs excluded (SmartPak + Modern Animal)

AI IconCapital Funding

  • Share repurchases: ~$200M executed during the quarter
  • Cash: ~$520M cash/cash equivalents/marketable securities; >$1B total available liquidity including revolver
  • Debt/capital structure: $600M Term Loan B launched; intent to target net leverage below 2x adjusted EBITDA over time

AI IconStrategy & Ops

  • Automation and scale: utilization of fulfillment productivity to reduce variable costs and support OpEx leverage
  • AI embedded across customer service, pharmacy operations, fulfillment, and marketing workflows
  • AI-driven efficiencies expected to contribute low tens of millions of dollars benefit in fiscal 2026, ramping more meaningfully into 2027+
  • Chewy Vet Care (CVC) expansion via Modern Animal; expects ~60 clinics exiting FY26 with embedded steady-state revenue contribution approaching ~$290M

AI IconMarket Outlook

  • FY2026 net sales guidance: ~$13.40B to ~$13.55B (+6.3% to +7.5% YoY)
  • FY2026 net sales incremental contributions: ~$80M from SmartPak; ~$70M from Modern Animal
  • FY2026 adjusted EBITDA margin guidance maintained: 6.6% to 6.8% (midpoint ~100 bps YoY expansion); implied ~$900M adjusted EBITDA at midpoint
  • Q2 FY2026 net sales guidance: ~$3.30B to ~$3.33B (+~6% to +7% YoY)
  • Q2 FY2026 adjusted EBITDA margin introduced: 6.3% to 6.4% (midpoint +~50 bps YoY); includes mid-single-digit million fuel surcharge headwind
  • Q2 adjusted diluted EPS guidance: ~$0.36
  • FY2026 active customer additions expected to trend to lower end of prior 150k–250k net adds/quarter range
  • Quarterly gross margin cadence: Q2 contract modestly YoY due to difficult comps from nonrecurring MAP pricing benefits in Q2 FY25; full-year gross margin still expected to expand

AI IconRisks & Headwinds

  • Short-term NSPAC headwind from incremental pressure on premiumization and product attach rates (modestly more challenged consumer environment since original outlook)
  • Muted impact of Autoship flow changes and enhanced digital advertising bidding algorithms due to macro
  • Modern Animal clinics expected to be a modest margin rate drag in 2026 despite profitable 4-wall maturity
  • Gross margin timing pressure in Q2 from nonrecurring MAP pricing benefits comp; elevated fuel surcharge costs expected to flow through

Q&A: Analyst Interest

  • Topic: Q2-to-back-half margin phasing drivers and sequential improvement mechanics: Management described Q2 as primarily timing/phasing—SG&A expansion broadly flat vs Q1 and much of the year. Sequential margin improvement is attributed to gross margin curve normalization, with Q2 2025 having outsized seasonality/nonrecurring MAP effects, and back-half reflecting “more normal” cadence and SG&A leveraging.
  • Topic: Consumer behavior deterioration granularity and cohort/income differences: Management said they do not track demographic-specific behavioral deviations periodically (only twice-yearly). They emphasized positive cumulative reorder rate trends across new and reactivated customers by cohort, with only broad premiumization and modest attach-rate pressure acknowledged, not demographic-specific deterioration.
  • Topic: Macro vs Chewy-specific share dynamics and AI savings trajectory: Management asserted confidence is macro-driven, citing solid share gain indicators—customer reactivation/churn improvements, branded search/direct traffic migrating to Chewy, and increased absolute clicks despite weaker industry impressions. For AI, management confirmed fiscal 2027 expectation remains “$50M plus” beyond the low-tens-of-millions fiscal 2026 benefit.

Sentiment: MIXED

Note: This summary was synthesized by AI from the CHWY Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for CHWY.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (CHWY)

© 2026 Stock Market Info — Chewy, Inc. (CHWY) Financial Profile